nitroxyl has been researched along with pioglitazone in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Nagasaki, Y; Sakharkar, MK; Thangavel, S; Yoshitomi, T | 1 |
1 other study(ies) available for nitroxyl and pioglitazone
Article | Year |
---|---|
Redox nanoparticle increases the chemotherapeutic efficiency of pioglitazone and suppresses its toxic side effects.
Topics: Administration, Oral; Animals; Antineoplastic Agents; Apoptosis; Biocompatible Materials; Cell Line, Tumor; Cell Survival; Drug Carriers; Drug Liberation; Free Radical Scavengers; Humans; Hydrophobic and Hydrophilic Interactions; Liver; Male; Mice, Inbred BALB C; Mice, Nude; Nanoparticles; Nitrogen Oxides; Oxidation-Reduction; Particle Size; Pioglitazone; Polyethylene Glycols; Polystyrenes; Prostatic Neoplasms; Reactive Oxygen Species; Thiazolidinediones | 2016 |